In vivo assessment of possible probiotic properties of Zymomonas mobilis in a Wistar rat model
Full Text
Reprint PDF

Keywords

health benefit
safety
Zymomonas mobilis

How to Cite

1.
de Azerêdo GA, Montenegro Stamford TL, de Souza EL, Fonseca Veras F, Rodrigues de Almeida E, de Araújo JM. In vivo assessment of possible probiotic properties of Zymomonas mobilis in a Wistar rat model. Electron. J. Biotechnol. [Internet]. 2010 Mar. 15 [cited 2024 Nov. 21];13(2):0-. Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/v13n2-4

Abstract

In recent years the incorporation of probiotic bacteria into foods has received increasing scientific interest for health promotion and disease prevention. The safety and probiotic properties of Zymomonas mobilis CP4 (UFPEDA-202) was studied in a Wistar rat model fed the 109 colony forming units (cfu)/mL-1 of the assayed strain for 30 days. No abnormal clinical signs were noted in the group receiving viable cells of Z. mobilis and water (control) during the period of the experiment. There were no significant difference (p > 0.05) in feed intake and weight gain among mice fed the Z. mobilis in comparison to the control group. No bacteria were found in blood, liver and spleen of any animals. Mice receiving Z. mobilis showed significantly differences (p ;< 0.05) in total and differential leucocytes count, excepting for neutrophils, after the experimental period. Otherwise, it was not found in control group. Histological examination showed that feeding mice with Z. mobilis caused no signs of adverse effects on gut, liver and spleen. From these results, Z. mobilis CP4 (UFEPEDA-202) is likely to be nonpathogenic and safe for consumption, and could have a slight modulating effect on immunological performance in mice.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.